Publicaciones en las que colabora con ANTONIO ENTRENA GUADIX (29)

2011

  1. BIOrienta2.orientación a futuros farmacéuticos: La Investigación en biomedicina como carrera profesional

    Univest 2011: III Congreso Internacional "La autogestión del aprendizaje" (Universitat de Girona = Universidad de Gerona)

2007

  1. Cyclophanes and bicyclophanes: Fascinating molecules in organic chemistry

    Targets in Heterocyclic Systems, Vol. 11, pp. 431-448

  2. Design, syntheses, biological evaluation, and docking studies of 2-substituted 5-methylsulfonyl-1-phenyl-1H-indoles: Potent and selective in vitro cyclooxygenase-2 inhibitors

    ChemMedChem, Vol. 2, Núm. 1, pp. 88-100

  3. Erratum: (Current Medicinal Chemistry (2006) vol. 13 (2))

    Current Medicinal Chemistry

2006

  1. (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs

    Current Medicinal Chemistry, Vol. 13, Núm. 11, pp. 1231-1248

  2. Insight into the inhibition of human choline kinase: Homology modeling and molecular dynamics simulations

    ChemMedChem, Vol. 1, Núm. 11, pp. 1216-1228

  3. Study of the factors that control the ratio of the products between 5-fluorouracil, uracil, and tetrahydrobenzoxazepine O,O-acetals bearing electron-withdrawing groups on the nitrogen atom

    Journal of Organic Chemistry, Vol. 71, Núm. 3, pp. 1043-1054

2005

  1. Rules for predicting the conformational behavior of saturated seven-membered heterocycles

    Arkivoc, Vol. 2005, Núm. 6, pp. 88-108

  2. Synthesis and NMR studies on a C3-symmetrical triquinolina triscationic bicyclophane

    Journal of Organic Chemistry, Vol. 70, Núm. 14, pp. 5748-5751

  3. Synthesis of novel 1-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-uracil and -thymine, and their corresponding S-oxidized derivatives

    Tetrahedron, Vol. 61, Núm. 43, pp. 10363-10369

  4. Towards a model for the inhibition of choline kinase by a new type of inhibitor

    European Journal of Medicinal Chemistry, Vol. 40, Núm. 3, pp. 315-319

2003

  1. Conformational Dynamics of a Bispyridinium Cyclophane

    Journal of Organic Chemistry, Vol. 68, Núm. 22, pp. 8697-8699

  2. Medium benzene-fused oxacycles with the 5-fluorouracil moiety: Synthesis, antiproliferative activities and apoptosis induction in breast cancer cells

    Tetrahedron, Vol. 59, Núm. 29, pp. 5457-5467

  3. Neighbouring-group participation as the key step in the reactivity of acyclic and cyclic salicyl-derived O,O-acetals with 5-fluorouracil. Antiproliferative activity, cell cycle dysregulation and apoptotic induction of new O,N-acetals against breast cancer cells

    Tetrahedron, Vol. 59, Núm. 40, pp. 8017-8026

2002

  1. 1H and 13C chemical shifts for bis(benzopyridinium) dibromides with semirigid aromatic linkers

    Magnetic Resonance in Chemistry, Vol. 40, Núm. 8, pp. 554-556

  2. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models

    Journal of Medicinal Chemistry, Vol. 45, Núm. 7, pp. 1402-1411

2001

  1. LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase

    European Journal of Medicinal Chemistry, Vol. 36, Núm. 3, pp. 215-225

2000

  1. Los nuevos retos de la industria farmacéutica

    Ars pharmaceutica, Vol. 41, Núm. 2, pp. 149-157

1997

  1. A New Systematization of the Conformational Behavior of Seven-Membered Rings. Isoclinal Anomeric and Related Orientations

    Journal of Organic Chemistry, Vol. 62, Núm. 2, pp. 337-349

1996

  1. 5-Fluorouracil derivatives. 1. Acyclonucleosides through a tin (IV) chloride-mediated regiospecific ring opening of alkoxy-1,4-diheteroepanes

    Tetrahedron, Vol. 52, Núm. 26, pp. 8907-8924